Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yinpian is a biotechnology company focused on the modernization of Traditional Chinese Medicine (TCM) through the integration of artificial intelligence, high-throughput screening, and multi-omics analysis. The company aims to identify active compounds within traditional herbal formulations and optimize them for modern therapeutic applications, particularly in metabolic and inflammatory diseases. By leveraging its proprietary platform, Yinpian bridges the gap between ancient medicinal knowledge and contemporary drug discovery standards. Their business model includes internal drug development as well as collaborations with pharmaceutical partners to validate and standardize TCM-derived products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yinpian.